Swedish drugmaker SOBI to acquire Seattle biotech company CTI BioPharma for $1.7B CTI BioPharma, a Seattle-based publicly traded biotech company developing therapies for blood-related cancers, is set to be acquired in a… Read More
Cancer drug maker CTI BioPharma lays off 50% of workforce CTI BioPharma announced Thursday that it will let go of half its employees in order to create more runway to… Read More
Tech Moves: Appuri appoints Todd Owens as CEO; Zipwhip adds to leadership; and more Seattle-based Appuri, a startup using big data in an attempt to predict customer dissatisfaction, has appointed a new CEO: former… Read More
